Quick answer
Reliance, Inc. (RS) reported revenue of $14.29B and net income of $739.4M for the fiscal year ended 2025-12-31, up 3.3% from $13.84B the year before, per its 10-K filed with the SEC on 2026-02-26. Long-term debt stood at $1.42B.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $14.29B | $739.4M | $1.42B |
| 2024 (FY ending 2024-12-31) | $13.84B | $875.2M | $742.8M |
| 2023 (FY ending 2023-12-31) | $14.81B | $1.34B | $1.14B |
| 2022 (FY ending 2022-12-31) | $17.02B | — | $1.14B |
| 2021 (FY ending 2021-12-31) | $14.09B | — | $1.64B |
| 2020 (FY ending 2020-12-31) | $8.81B | — | $1.64B |
| 2019 (FY ending 2019-12-31) | $10.97B | — | $1.52B |
| 2018 (FY ending 2018-12-31) | $11.53B | — | $2.14B |
| 2017 (FY ending 2017-12-31) | $9.72B | — | $1.81B |
| 2016 (FY ending 2016-12-31) | $8.61B | — | $1.85B |
Frequently asked questions
What is Reliance, Inc.'s annual revenue?
Reliance, Inc. (RS) reported revenue of $14.29B and net income of $739.4M for the fiscal year ended 2025-12-31, up 3.3% from $13.84B the year before, per its 10-K filed with the SEC on 2026-02-26. Long-term debt stood at $1.42B.
What is RS's profit margin?
Reliance, Inc.'s net margin was 5.2% in the fiscal year ended 2025-12-31.
Related
- RPRX revenue, net income and debt history (Royalty Pharma plc)
- RRC revenue, net income and debt history (Range Resources Corp)
- RRX revenue, net income and debt history (Regal Rexnord Corp)
- RSG revenue, net income and debt history (Republic Services, Inc.)
- RTX revenue, net income and debt history (Rtx Corporation)
- RVMD revenue, net income and debt history (Revolution Medicines, Inc.)
- RVTY revenue, net income and debt history (Revvity, Inc)
- RYAN revenue, net income and debt history (Ryan Specialty Holdings, Inc.)
Last updated Oct 16, 2026, 10:42 PM ET. Data only, not financial or tax advice.